Gala vs Noom

Neither Gala nor Noom has an FDA warning letter on record. On compounded semaglutide injection, the standing prices are within $1 a month of each other: $179 at Gala and $179 at Noom.

To see where both sit among the other sellers, read our best weight-loss injection providers board.

By Ruth Calder · Enforcement Editor
Editorially reviewed. Not medical advice · How we verify contentLast reviewed

The record

Gala / Noom

Featured pick (affiliate partner)

Gala logo

Gala

8.5/10

Noom logo

Noom

5.8/10

FDA warning letters
None on record
None on record
Pharmacy
None named in our record
None named in our record
Lowest standing price
$179/moCompounded semaglutide injection
$179/moCompounded semaglutide injection
States
All 50 states
No state list published
Checked
Prices captured Record checked October 2026
Prices captured Record checked October 2026

Gala is our featured pick on this page because it is an affiliate partner: we are paid if you sign up through our link. Noom pays us nothing. The scores are computed the same way for both and are shown as computed (Gala 8.5, Noom 5.8). How we are paid

What the record shows

  1. 01

    Neither Gala nor Noom has an FDA warning letter on record.

  2. 02

    Neither names the pharmacy that compounds its medication.

  3. 03

    On compounded semaglutide injection, the standing prices are within $1 a month of each other: $179 at Gala and $179 at Noom.

  4. 04

    Only Gala lists a price for compounded tirzepatide injection and brand-name semaglutide pen. Only Noom lists a price for brand-name tirzepatide pen.

  5. 05

    Gala lists all 50 states. Noom publishes no state list.

Prices and terms, product by product

A price is set against the other side only for the same product, and only when both are standing monthly or 4-week rates. Those pairs are compared by yearly cost.

Gala

Noom

Compounded semaglutide injection

$179/mo

$2,148 a year

$179/mo

$2,148 a year

Compounded tirzepatide injection

$179/mo

$2,148 a year

Not sold or not priced
Brand-name semaglutide pen

$1,299/mo

$15,588 a year

Not sold or not priced
Brand-name tirzepatide pen
Not sold or not priced

$349/mo

$4,188 a year

Price includes
Medication, clinician visits, shipping
Clinician visits, coaching
Cancel any time
Yes, stated
Yes, stated
Minimum term
Yearly plan for the $179 rate; 72 hours' notice before the billing date to cancel
Not stated
Refunds
No refund on cancellation; full refund only if the medical provider disqualifies you
Refunds only before a prescription is written; renewal charges are not refunded

Read off each seller’s own pages. Gala: October 17, 2026. Noom: October 30, 2026. Every plan and dose we hold is on the full review.

The case for each

The case for Gala

8.5/10
Featured pick (affiliate partner)
  • Sells compounded tirzepatide injection and brand-name semaglutide pen, which Noom does not price
  • Names no compounding pharmacy

The case for Noom

5.8/10
  • Sells brand-name tirzepatide pen, which Gala does not price
  • Names no compounding pharmacy
  • Publishes no state list

Scores

Gala 8.5 · Noom 5.8 out of 10. Six weighted parts.

Value25%

7.9A
vs
B
0.9

Effectiveness25%

10.0A
vs
B
10.0

User Experience15%

8.0A
vs
B
8.0

Trust & Safety15%

7.5A
vs
B
6.5

Accessibility10%

10.0A
vs
B
5.0

Support10%

7.0A
vs
B
4.0

The score is the same formula for every seller. Payment does not enter it. Method

Gala vs Noom: questions

Neither Gala nor Noom has an FDA warning letter on record. Letters are matched to a seller by company, domain and address, never by a similar name.
Neither names the pharmacy that compounds its medication.
Neither, by more than $1 a month. Gala charges $179 a month and Noom $179 a month.
Gala states you can cancel at any time; refunds: no refund on cancellation; full refund only if the medical provider disqualifies you. Noom states you can cancel at any time; refunds: refunds only before a prescription is written; renewal charges are not refunded.
Gala is our featured pick on this page because it is an affiliate partner: we are paid if you sign up through our link. Noom pays us nothing. The scores are computed the same way for both and are shown as computed (Gala 8.5, Noom 5.8).

Other sellers we are paid by

Affiliate partners outside this pair. Each has its own record and review, scored the same way.

Matched on molecule, form and price. Every pair we list · The register

Brand names on this page are registered marks. Novo Nordisk holds Wegovy®, Ozempic® and Rybelsus®; Eli Lilly holds Zepbound®, Mounjaro® and Foundayo®. Neither company has any tie to GLP Watchdog. Trademarks